To test whether the adaptive immune system is essential for EE-mediated tumor protection, mice were treated with either anti-CD4, anti-CD8, or anti-NK1.1 depletion antibodies in conjunction with SE or EE housing. This evidence concerns the gene CD8A and neoplasm.